Director/PDMR Shareholding

RNS Number : 2339X

Kainos Group plc

08 August 2018

 

08 August 2018

Kainos Group plc

("Kainos" or the "Company)

Director and PCA Dealing

The Company was notified on 08 August 2018 that Richard McCann, Director, has:

1.   exercised his 2015 PSP options over 68,345 ordinary shares of £0.005 in the Company ("Ordinary Shares"), at an exercise price of £0.005 per Ordinary Share; and

2.   exercised his 2015 SAYE options over 3,237 Ordinary Shares at an exercise price of £1.112 per Ordinary Share; and

3.   received a nil value transfer of 100,000 Ordinary Shares from his spouse/Person Closely Associated ("PCA").  

Following this notification, having retained the PSP and SAYE Ordinary Shares on exercise, Richard McCann and his PCA have a reportable shareholding of 6,211,582 Ordinary Shares in the issued share capital of the Company, constituting 5.19% of the issued share capital of the Company.

1.	Details of the person discharging managerial responsibilities / person closely associated
a.	Name	Richard McCann
2.	Reason for the notification
a.	Position/status	COO/CFO & PDMR
b.	Initial notification /Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Kainos Group plc
b.	LEI	213800H2PQMIF3OVZY47
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the Financial instrument/ type of instrument Identification code	Ordinary Shares of £0.005 each ISIN: GB00BZ0D6727
b.	Nature of the transaction	Exercise of Options and Retention of Shares Transfer of Shares from Spouse
c.	Price(s) and volume(s)	EXERCISE OF2015 PSP Price(s) Volume(s) £0.005 68,345 EXERCISE OF2015 SAYE Price(s) Volume(s) £0.005 3,237 TRANSFER OF SHARES FROM SPOUSE Price(s) Volume(s) NIL 100,000
d.	Aggregated information ·      Aggregated volume ·      Price	N/A
e.	Date of the transaction	PSP exercise and transfer to spouse - 07 August 2018 SAYE exercise - 08 August 2018
f.	Place of the transaction	Outside a trading venue

1.	Details of the person discharging managerial responsibilities / person closely associated
a.	Name	Kerry McCann
2.	Reason for the notification
a.	Position/status	PCA of Richard McCann (PDMR)
b.	Initial notification /Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Kainos Group plc
b.	LEI	213800H2PQMIF3OVZY47
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the Financial instrument/ type of instrument Identification code	Ordinary Shares of £0.005 each ISIN: GB00BZ0D6727
b.	Nature of the transaction	Transfer to Spouse
c.	Price(s) and volume(s)	TRANSFER OF SHARES TO SPOUSE Price(s) Volume(s) Nil 100,000
d.	Aggregated information ·      Aggregated volume ·      Price	N/A
e.	Date of the transaction	07 August 2018
f.	Place of the transaction	Outside a trading venue

Classification: Additional Regulated Information

Ends

For further information, please contact:

Kainos                                                                                         via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer

Investec Bank plc                                                                                 44 20 7597 5970

Patrick Robb / Sebastian Lawrence

Canaccord Genuity                                                                            [phone]

Simon Bridges / Emma Gabriel

FTI Consulting LLP                                                                            [phone]

Matt Dixon / Harry Staight

About Kainos

Kainos Group plc is a UK-based provider of Digital Services and Digital Platforms.

The Group's Digital Services include full lifecycle development and support of customised Digital Services for government and commercial customers. Kainos is also the leading European partner for Workday Inc. ('Workday') responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise and, now, government customers.

The Group's Digital Platforms comprise specialised digital products in the mobile healthcare and automated testing arenas. Smart is an automated testing platform for Workday customers; Evolve Electronic Medical Records ('EMR') is the market leading product for the digitisation of patient notes in the Acute sector of the NHS; and Evolve Integrated Care ('IC') is a SaaS-based integrated care platform for the NHS and international healthcare providers; and Smart is an automated testing platform for Workday customers.

Kainos has over 1,150 people across eleven offices in Europe and the USA, working interchangeably across its Services and Platforms divisions.

Kainos is listed on the London Stock Exchange (LSE: KNOS). For further information, please visit www.kainos.com

 

END

 

 

DSHFKFDDNBKDCFK